Home › Acute Myeloid Leukemia › Vermont › Burlington
Pag-aaral pangklinika para sa Acute Myeloid Leukemia sa Burlington, VT
Isang pag-aaral para sa Acute Myeloid Leukemia ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Burlington. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.
Opisyal na teksto ng pag-aaral (English)
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
Nagre-recruitPhase 2
- University of Vermont Medical Center, Burlington
- University of Vermont and State Agricultural College, Burlington
Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)
Nagre-recruitPhase 2
- University of Vermont Medical Center, Burlington
- University of Vermont and State Agricultural College, Burlington
Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)
Nagre-recruitPhase 2
- University of Vermont Medical Center, Burlington
- University of Vermont and State Agricultural College, Burlington
Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)
Nagre-recruitPhase 2
- University of Vermont Medical Center, Burlington
- University of Vermont and State Agricultural College, Burlington
A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations
Nagre-recruitPhase 3
- University of Vermont and State Agricultural College, Burlington
Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML
Nagre-recruitPhase 3
- University of Vermont Medical Center, Burlington
Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia
Nagre-recruitPhase 1
- University of Vermont, Burlington
Pag-aaral para sa Acute Myeloid Leukemia sa ibang lungsod
- Houston, TX85 pag-aaral
- New York City, NY51 pag-aaral
- Boston, MA44 pag-aaral
- Seattle, WA41 pag-aaral
- Baldwin Park, CA40 pag-aaral
- Columbus, OH35 pag-aaral
- Philadelphia, PA34 pag-aaral
- Durham, NC33 pag-aaral
- Atlanta, GA31 pag-aaral
- Tampa, FL29 pag-aaral
- Chicago, IL26 pag-aaral
- Portland, OR25 pag-aaral
Iba pang pag-aaral sa Burlington
- Pagkabigo ng Puso8 pag-aaral
- Kanser (lahat ng uri)6 pag-aaral
- COPD5 pag-aaral
- Kanser sa Suso5 pag-aaral
- Leukemia4 pag-aaral
- Sakit ni Parkinson4 pag-aaral
- Kanser sa Baga4 pag-aaral
- Sakit sa Puso at Ugat ng Dugo4 pag-aaral
- Cystic Fibrosis4 pag-aaral
- Non-Small Cell Lung Cancer4 pag-aaral
- Kanser sa Prostate4 pag-aaral
- Metastatic Cancer4 pag-aaral
Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.